What one share of Impact BioMedical holds
“We”, “IBO”), discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.
Impact BioMedical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | $0.01 |
| Cash and investments | $0.00 |
| Book value | $0.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | — | −$2.30 | — | — | — | $0.36 |
| 2025 | $0.00 | −$0.38 | — | — | — | $0.12 |
Common questions about Impact BioMedical
How much does one share of Impact BioMedical earn?
Over the last 12 months, each share of Impact BioMedical earned $0.01 of profit on $0.00 of sales, keeping about 2500¢ of every $1 (profit margin).
Does Impact BioMedical pay a dividend?
Impact BioMedical didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Impact BioMedical’s book value per share?
Impact BioMedical’s book value is $0.10 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Impact BioMedical have?
Each share of Impact BioMedical has $0.00 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.